NCT00000580View on ClinicalTrials.gov

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 1975

Study Completion Date

June 30, 1986

Conditions

Hepatitis BHepatitis, Viral, HumanLiver Diseases

Interventions

DRUG

immunoglobulins, intravenous

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000580 - Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin | Biotech Hunter | Biotech Hunter